Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements. (Q39862947)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555338%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555338%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

Guilherme Suarez-Kurtz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555338%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Esteban J Parra

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555338%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Kendra A Ross

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555338%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Abbigail W Bigham

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555338%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Melissa Edwards

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555338%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Agnes Gozdzik

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555338%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

17 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555338%20AND%20SRC:MED&resulttype=core&format=json

Journal of Human Genetics

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555338%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555338%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555338%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

582-589

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555338%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/jhg.2010.73

5 February 2020

exact match

0 references

cites work

Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Medication use leading to emergency department visits for adverse drug events in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

A regulatory science perspective on warfarin therapy: a pharmacogenetic opportunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Interactions of warfarin with drugs and food

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

The largest prospective warfarin-treated cohort supports genetic forecasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Stereoselective interaction between the R enantiomer of warfarin and cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

VKORC1: molecular target of coumarins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Equal proportion of adult male and female homozygous for the 677C ? T mutation in the methylenetetrahydrofolate reductase polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Ethnic differences in warfarin maintenance dose requirement and its relationship with genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

CYP4F2 genetic variant alters required warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Effects of CYP4F2 genetic polymorphisms and haplotypes on clinical outcomes in patients initiated on warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

The influence of ethnicity on warfarin dosage requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Genetic and clinical predictors of warfarin dose requirements in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Pharmacogenetics of warfarin: development of a dosing algorithm for brazilian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Validation of clinical testing for warfarin sensitivity: comparison of CYP2C9-VKORC1 genotyping assays and warfarin-dosing algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

The genomic distribution of population substructure in four populations using 8,525 autosomal SNPs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Genome scans of DNA variability in humans reveal evidence for selective sweeps outside of Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Genomic regions exhibiting positive selection identified from dense genotype data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Roles for vitamin K beyond coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

7 January 2021

CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

7 January 2021

Identifying positive selection candidate loci for high-altitude adaptation in Andean populations.

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

7 January 2021

VKORC1 and the vitamin K cycle

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2010.73

7 January 2021

Identifiers

DOI

10.1038/JHG.2010.73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555338%20AND%20SRC:MED&resulttype=core&format=json

release_azaizk5otzaa5pbylcyxqb4f2i

5 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/azaizk5otzaa5pbylcyxqb4f2i

24 November 2022

mapped directly with Wikidata item

1 reference